RhumbLine Advisers’s Scinai Immunotherapeutics SCNI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.98K | Buy |
3,483
+1,916
| +122% | +$4.39K | ﹤0.01% | 3890 |
|
|
2025
Q1 | $4.17K | Sell |
1,567
-86
| -5% | -$229 | ﹤0.01% | 3927 |
|
|
2024
Q4 | $5.5K | Hold |
1,653
| – | – | ﹤0.01% | 3940 |
|
|
2024
Q3 | $5.85K | Buy |
1,653
+515
| +45% | +$1.82K | ﹤0.01% | 3959 |
|
|
2024
Q2 | $3.24K | Buy |
1,138
+473
| +71% | +$1.35K | ﹤0.01% | 4148 |
|
|
2024
Q1 | $3.44K | Buy |
665
+134
| +25% | +$693 | ﹤0.01% | 4031 |
|
|
2023
Q4 | $3.08K | Buy |
531
+176
| +50% | +$1.02K | ﹤0.01% | 4050 |
|
|
2023
Q3 | $3.08K | Buy |
355
+5
| +1% | +$43 | ﹤0.01% | 4060 |
|
|
2023
Q2 | $4.76K | Buy |
+350
| New | +$4.76K | ﹤0.01% | 4097 |
|